YM598 Added to Mitoxantrone/Prednisone to Control Pain in Metastatic Prostate Cancer Patients No Longer Responding to Hormone Therapy

Stopped early · Phase 2

Conditions studied: Hormone-Refractory Prostate Cancer, Prostatic Neoplasms

In brief

The purpose of this study is to determine if patients who take YM598 in addition to mitoxantrone and prednisone (standard therapy) experience improvement in the pain associated with prostate cancer metastases in the bone.

Key facts

Study ID

NCT00048659

Run by

Astellas Pharma Inc

Expected to finish

2004-06-01

Last updated by the study team

2012-06-07

Who can join

Age: 18 and older. Sex: male. Healthy volunteers: not accepted.

Where it is running

• San Bernardino Urological Associates — San Bernardino, California, United States
• Western Clinical Research, Inc. — Torrance, California, United States
• Shands Hospital — Gainesville, Florida, United States
• Sylvester Comprehensive Cancer Center — Miami, Florida, United States
• Georgia Urology,PA Research Institute — Atlanta, Georgia, United States
• University of Chicago, Section of Hematology/Oncology — Chicago, Illinois, United States
• University of Illinois, Department of Urology — Chicago, Illinois, United States
• Michiana Hematology/Oncology — South Bend, Indiana, United States
• The Urologic Institute of New Orleans — Gretna, Louisiana, United States
• Henry Ford Hospital — Detroit, Michigan, United States
• Washington University School of Medicine — St Louis, Missouri, United States
• Memphis Cancer Center — Memphis, Tennessee, United States
• Virginia Mason Medical Center — Seattle, Washington, United States
• Department of Medical Oncology, The Canberra Hospital — Canberra, Australia
• Department of Medical Oncology, Concord Hospital Medical Centre — Concord, Australia
• Division of Oncology Ward, Royal Brisbane Hospital — Herston, Australia
• Department of Clinical Oncology, Royal North Shore Hospital — St Leonards, Australia
• Cancer Care Centre, St. George Hospital — Sydney, Australia
• Department of Medical Oncology, Newcastle Mater Hospital — Waratah, Australia
• Southern Medical Day Care Centre — Wollongong, Australia
• Queen Elizabeth Hospital, Clinical Hematology & Oncology — Woodville, Australia
• Cliniques Universitaires St-Luc, Service d'Urologie — Brussels, Belgium
• Centre Hospitalier Notre Dame et Reine Fabiola, Service d'oncologie — Charleroi, Belgium
• Centre Paul Papin — Angers, France
• Alaska Clinical Research Center, LLC — Anchorage, Alaska, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.